Racial Disproportionality in Covid Clinical Trials To provide the necessary data for generalizing
efficacy and safety outcomes across racial groups, Covid-19 clinical trials must prioritize …

A rapidly emerging global outbreak of monkeypox virus infection (MPXV) in over 50 non-endemic
countries was identified in May 2022. We report the case and images of a patient with …

Background Sepsis is a global health challenge associated with significant morbidity and
mortality. Detrimental sepsis effects are attributed to excessive inflammation or a “cytokine …

Objectives: To compare characteristics and clinical manifestations of monkeypox (MPX)
between people with and without HIV in the United States. Design: Retrospective cohort study …

Purpose of Review The goal of this review is to provide an update on the epidemiology,
diagnosis, and treatment of opportunistic fungal infections in patients with human …

It is unclear if there is an association between COVID‐19 and cryptococcosis. Therefore,
this study aimed to describe the clinical features, risk factors, and outcomes associated with …

Cryptococcus spp. conveys a high disease burden among immunocompromised hosts.
Clinicians must consider numerous variables and factors in a dynamic way to offer the best …

Background: HIV-negative patients have substantial mortality from Pneumocystis jirovecii
pneumonia (PJP). We lack predictors of HIV-negative PJP-associated mortality. Objective: We …

Introduction As a result of improved safe and effective therapeutic options for human
immunodeficiency virus (HIV), life expectancy of those living with HIV is increasing leading to new …

Background: There is increasing interest in the use of oritavancin and dalbavancin for
complicated Gram-positive infections as an alternative to in-hospital intravenous or outpatient …